Coronary artery disease in systemic lupus erythematosus: Risk factors, assessment, and prevention

Journal of Clinical Rheumatology

Volumn 3, Issue 4, 1997, Pages 203-210

  Hashkes, Philip J ^a   Wexler, Laura F ^a,b   Passo, Murray H ^a,c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Coronary artery disease; Systemic lupus erythematosus

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ARTICLE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030770747     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199708000-00005     Document Type: Article

References (57)

1. Dubois EL, Wierzchowiecki M, Cox MB, Weiner JM. Duration and death in systemic lupus erythematosus. An analysis of 249 cases. JAMA 1974;227:1399-1402.
2. Urowitz MB, Bookman AAM, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-5.
3. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 1989;68:141-50.
4. Worrall JG, Snaith ML, Batchelor JR, Isenberg DA. SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up. Q J Med 1990;74:319-30.
5. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991;21:55-64.
6. Abu-Shakra M, Urowitz MB, Gladman DD, Gouhg J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 1995;22:1259-64.
7. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus: long-term followup of an inception cohort. Arthritis Rheum 1995;38:1492-9.
8. Meiler J, Conde C, Deppisch LM, Donoso E, Dack S. Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus. Am J Cardiol 1987;5:309-14.
9. Shearn MA. The heart in systemic lupus erythematosus. Am Heart J 1959;58:452-66.
10. Ishikawa S, Segar WE, Gilbert EF, Burkholder PM, Levy JM, Viseskul C. Myocardial infarct in a child with systemic lupus erythematosus. Am J Dis Child 1978;132:696-9.
11. Bonfiglo TA, Botti RE, Hagstrom JWC. Coronary arteritis, occlusion and myocardial infarction due to lupus erythematosus. Am Heart J 1972;83:153-8.
12. Homcy CJ, Liberthson RR, Fallon JT, Gross S, Miller LM. Ischemic heart disease in systemic lupus erythematosus in the young patient. Am J Cardiol 1982;49:478-84.
13. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-9.
14. Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol 1987; 14 Suppl 13:223-6.
15. Badui E, Garcia-Rubi D, Robles E, Jimenez J, Juan L, Deleze M, et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985;36:431-41.
16. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985;110:1257-65.
17. Hejtmancik MR, Wright JC, Quint R, Jennings FL. The cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1964; 68:119-30.
18. Strauer BE, Brune I, Schenk H, Knoll D, Perings E. Lupus cardiomyopathy: cardiac mechanics hemodynamics, and coronary blood flow in uncomplicated systemic lupus erythematosus. Am Heart J 1976;92:715-22.
19. Hosenpud JD, Montanaro A, Hart MV, Haines JE, Specht HD, Bennett RM, et al. Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am J Med 1984;77:286-92.
20. Kong TQ, Kellum RE, Haserick JR. Clinical diagnosis of cardiac involvement in systemic lupus erythematosus: a correlation of clinical and autopsy findings in thirty patients. Circulation 1962;26:7-11.
21. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 1985;55:87-98.
22. Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematosus. Quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med 1981;70:775-81.
23. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. Am J Med 1975;58:243-64.
24. Asherson RA, Khamashta MA, Baguley E, Oakley CM, Rowell NR, Hughes GRV. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med 1989;272:1103-15.
25. Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S. Cardiovascular disease in systemic lupus erythematosus: a study of 75 patients from a defined population. Medicine (Baltimore) 1992;71:216-23.
26. Rosner S, Ginzier EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 1982;25:612-7.
27. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990;33:37-48.
28. De Inocencio J, Lovell DJ. Cardiac function in systemic lupus erythematosus. A pediatric perspective. J Rheumatol 1994;21:2147-56.
29. Petri M, Spence D, Bone LR, Hochberg MC. Coronary artery disease risk factors in the John Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine 1992;71:291-302.
30. Ansari A, Larson PH, Bales HD. Cardiovascular manifestations of systemic lupus erythematosus: current perspective. Prog Cardiovasc Dis 1985;27:421-34.
31. Bidani AK, Roberts JL, Schwartz KM, Lewis EJ. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 1980;69:849-58.
32. Wilson VE, Eck SL, Bates ER. Evaluation and treatment of acute myocardial infarction complicating systemic lupus erythematosus. Chest 1992;101:420-4.
33. Petri M, Lakatta C, Magder L, Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994;96:254-9.
34. Ilowite NT, Samuel P, Ginzler E, Jacobson MS. Dyslipoproteinemia in pediatric lupus erythematosus. Arthritis Rheum 1988;31:859-63.
35. Ettinger WH, Goldberg AP, Applebaum-Bowden D, Hazzard WR. Dyslipoproteinemia in systemic lupus erythematosus: effects of corticosteroids. Am J Med 1987;83:503-8.
36. Lahita RG, Rivkin E, Cavanagh I, Romano P. Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1993;36:1566-74.
37. Smith GW, Hannan SF, Scott PJ, Simpson IJ. Immune complex-like activity associated with abnormal serum lipoprotein in systemic lupus erythematosus. Clin Exp Immunol 1982;48:8-16.
38. Nashel DJ. Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med 1986;80:925-9.
39. Aranow C, Enoch L, Barland P. Lipoprotein profiles and corticosteroid treatment in systemic lupus erythematosus [abstract]. Arthritis Rheum 1990;33 Suppl:S12.
40. Klemp P, Cooper RC, Strauss FJ, Jordaan ER, Przybojewski JZ, Nel N. Anti-cardiolipin antibodies in ischemic heart disease. Clin Exp Immunol 1988;74:254-7.
41. Hamsten A, Norberg R, Bjorkholm M, De Faire U, Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 1986;1:113-6.
42. Morton KE, Gavahan TP, Kirilis SA, Daggard GE, Baron DW, Hickie JB, et al. Coronary artery bypass graft failure: an autoimmune phenomenon? Lancet 1986;2:1353-6.
43. Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho K, Palosuo T. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993;341:923-5.
44. Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996; 348:1120-4.
45. Robinson K, Mayer E, Jacobson DW. Homocysteine and coronary artery disease. Cleve Clin J Med 1994;61:438-50.
46. McDermott EM, Powell RJ. Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide. Ann Rheum Dis 1996;55:224-9.
47. Bahl VK, Aradhye S, Vasan RS, Malhotra A, Reddy KS, Malaviya AN. Myocardial systolic function in systemic lupus erythematosus: a study based on radionuclide ventriculography. Clin Cardiol 1992;15:433-5.
48. Patterson RE, Horowitz SF, Eisner RL. Comparison of modalities to diagnose coronary artery disease. Semin Nucl Med 1994;4:286-310.
49. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993;87 Suppl II: 56-65.
50. Hearth-Holmes M, Baethge BA, Broadwell L, Wolf RE. Dietary treatment of hyperlipidemia in patients with systemic lupus erythematosus. J Rheumatol 1995;22:450-4.
51. Ilowite NT, Copperman N, Leicht T, Kwong T, Jacobson MS. Effects of dietary modification and fish oil supplementation in on dyslipoproteinemia in pediatric systemic lupus erythematosus. J Rheumatol 1995;22:1347-51.
52. Wallace DJ, Metzger AL, Stecher VJ, Turnbull BA, Kern PA. Cholesterol lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. Am J Med 1990;89:322-6.
53. Wallace DJ. Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus? Arthritis Rheum 1987;30:1435-6.
54. McMurray RW, Weidensaul D, Allen SH, Walker SE. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 1995;22:2084-91.
55. Hammerman H, Kloner RA, Hale S, Schoen FJ, Braunwald E. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation 1983;68:446-53.
56. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987;17:126-41.
57. Garcia-Rubira JC, Garcia-Martinez JT, Cruz JM. Thrombolytic therapy for a patient with systemic lupus erythematosus and acute myocardial infarction. Int J Cardiol 1990;29:243-4.